We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
ACD/Labs Logo

ACD/Labs

Advanced Chemistry Development (ACD/Labs) develops and commercializes informatics solutions for chemical, biochemical and pharmaceutical research and development. Their expertise lies in vendor-agnostic spectroscopic and chromatographic data processing and prediction, physicochemical and absorption, distribution, metabolism, excretion and toxicity (ADME-Tox) property prediction, analytical knowledge management, interactive reporting and integrating analytical data with chemical structures to help protect and leverage valuable research knowledge.

Latest Content

Scientists collaborating at a laptop in a lab, reflecting ACD/Labs’ 2025 software upgrades that enhance digital R&D workflows.
Product News

ACD/Labs Announces Version 2025 of Software on Its Spectrus® & Percepta® Platforms

ACD/Labs releases Version 2025 with expanded integrations, improved automation and enhanced analytical and predictive capabilities.
Laboratory scientist examining results, representing modern data analysis and scientific software integration.
Product News

Revvity To Acquire ACD/Labs To Expand Its Signals Software Capabilities

Revvity will acquire ACD/Labs to enhance Signals software with advanced analytical tools, delivering unified workflows from discovery to manufacturing.
Two female scientists in white lab coats collaborating while looking at a laptop in a modern laboratory setting, surrounded by lab equipment and digital data displays, symbolizing the use of a software platform in scientific research.
Product News

ACD/Labs Announces Katalyst D2D® Software Release With Expanded Capabilities for Accelerated Pharmaceutical Development

ACD/Labs updates Katalyst D2D with new automation, data integration and workflow tools to speed drug development.
Hand holding a glowing AI icon surrounded by digital network and technology symbols.
Product News

ACD/Labs and Covestro Announce Collaboration Delivering AI-Supported Solvent Selection at PhysChem Forum 2025

ACD/Labs and Covestro partner to add AI-powered solvent recommendation tools to the Percepta platform.
Futuristic looking blue drug capsule sitting on a digitalized interface.
Product News

Redefining Pharmaceutical R&D Through AI and the Digitalized Physical DMTA Cycle

A major new two-part white paper series from ACD/Labs examines how AI-enabled design-make-test-analyze (DMTA) cycles can overcome fragmented workflows in drug discovery and development.
3D stick and ball molecular structure emerging from a red drug capsule.
Industry Insight

Faster, More Confident Small Molecule Structure Verification in Pharmaceutical R&D

Structure verification by NMR is a vital task in drug discovery but can be slow and subjective. This article explores how ASV transforms it into a scalable, consistent and reliable process.
Computer chips on flexible sheets.
Product News

ACD/Labs Releases State-of-the-Industry Report Highlighting Trends in Chemical Structure Elucidation & Verification

ACD/Labs, an informatics company that develops and commercializes software in support of digitalized R&D, released its 2025 Structure Elucidation & Verification Report.
A scientist holding out their palm with a red and white capsule in it.
Product News

ACD/Labs Launches Version 2024 of Spectrus Software for Digitalized, Data-Driven R&D

The latest annual release of analytical and chemical knowledge management software will facilitate decision-making and collaboration for laboratory scientists and help integrate AI into chemistry workflows.
How Do Spreadsheets Hold Back Pharma Innovation? content piece image
Industry Insight

How Do Spreadsheets Hold Back Pharma Innovation?

Technology Networks spoke to Jesse Harris to learn why spreadsheets can be a bottleneck for pharma research and explore how they compare to laboratory informatics tools.
Advertisement